Mark L. Jacobson, Chief Operating Officer at Axsome Therapeutics, Inc. (AXSM), sold 15,820 shares at $74.31 ($1.2M) on 2024-05-29, disclosed to the SEC on 2024-05-29.
Open-market sale of $1.2M AXSM by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.31 | 7,910 | $588K | 50.0% |
| 2 | $74.31 | 7,910 | $588K | 50.0% |
| Total | $74.31 avg | 15,820 | $1.2M | 100% |
| Filing → |
| AXSM | SELL | 2026-02-27 | $5.7M | — | Filing → |
| AXSM | SELL | 2025-09-22 | $1.2M | — | Filing → |
| AXSM | SELL | 2025-09-17 | $5.9M | — | Filing → |